470 related articles for article (PubMed ID: 1338940)
1. [Use of anti-D (Rh) IgG or intramuscular polyvalent human immunoglobulin in the treatment of chronic autoimmune thrombocytopenic purpura].
Vizcaíno G; Diez-Ewald M; Arteaga-Vizcaíno M; Torres E
Invest Clin; 1992; 33(4):165-74. PubMed ID: 1338940
[TBL] [Abstract][Full Text] [Related]
2. A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins.
Rodeghiero F; Schiavotto C; Castaman G; Vespignani M; Ruggeri M; Dini E
Haematologica; 1992; 77(3):248-52. PubMed ID: 1330848
[TBL] [Abstract][Full Text] [Related]
3. Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases.
Schiavotto C; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):22-8. PubMed ID: 8039754
[TBL] [Abstract][Full Text] [Related]
4. A single-institution, 20-year prospective experience with an affordable Fc-receptor blockade method to treat patients with chronic, refractory autoimmune thrombocytopenic purpura.
Estrada-Gómez R; Vargas-Castro O; Oropeza-Borges M; González-Carrillo ML; Pérez-Romano B; Ruiz-Argüelles GJ
Rev Invest Clin; 2007; 59(6):424-7. PubMed ID: 18402333
[TBL] [Abstract][Full Text] [Related]
5. ITP in childhood: difficulties in the individual treatment.
Grümayer ER; Haas OA; Panzer S; Gadner H
Klin Padiatr; 1986; 198(5):414-7. PubMed ID: 3784438
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of response to treatment in autoimmune thrombocytopenic purpura.
Gernsheimer T; Stratton J; Ballem PJ; Slichter SJ
N Engl J Med; 1989 Apr; 320(15):974-80. PubMed ID: 2927480
[TBL] [Abstract][Full Text] [Related]
7. The successful treatment of idiopathic thrombocytopenic purpura with the low dose non specific IgG component of anti D immunoglobulin.
Smith NA; Chakraverty RK; Boughton BJ
Clin Lab Haematol; 1990; 12(2):131-6. PubMed ID: 2119931
[TBL] [Abstract][Full Text] [Related]
8. Grand rounds. Immune globulin in the treatment of autoimmune thrombocytopenic purpura.
Wordell CJ; Stubits EA; Tietze KJ; Gaska JA; Cosgrove EM
Clin Pharm; 1985; 4(2):206-13. PubMed ID: 4039241
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of immune thrombopenia].
Egli F
Schweiz Med Wochenschr; 1991 Jun; 121(23):851-7. PubMed ID: 1713347
[TBL] [Abstract][Full Text] [Related]
10. [Rhesus(D)-IgG-antibodies in the treatment of autoimmune thrombocytopenia].
Giers G; Salama A; Mueller-Eckhardt C
Dtsch Med Wochenschr; 1992 Jan; 117(1):1-5. PubMed ID: 1730192
[TBL] [Abstract][Full Text] [Related]
11. Low-dose autologous in vitro opsonized erythrocytes. Radioimmune method and autologous opsonized erythrocytes for refractory autoimmune thrombocytopenic purpura in adults.
Ambriz R; Muñóz R; Pizzuto J; Quintanar E; Morales M; Avilés A
Arch Intern Med; 1987 Jan; 147(1):105-8. PubMed ID: 3026270
[TBL] [Abstract][Full Text] [Related]
12. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
Vianelli N; Galli M; de Vivo A; Intermesoli T; Giannini B; Mazzucconi MG; Barbui T; Tura S; Baccaranion M;
Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672
[TBL] [Abstract][Full Text] [Related]
15. Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy?
Bussel JB; Kaufmann CP; Ware RE; Woloski BM
Am J Hematol; 2001 May; 67(1):27-33. PubMed ID: 11279654
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of idiopathic thrombocytopenic purpura in adults with high-dosage immunoglobulins].
Busch FW; Ostendorf P; Schnaidt M; Wernet P; Waller HD
Dtsch Med Wochenschr; 1983 Aug; 108(34):1284-7. PubMed ID: 6684019
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura.
Ramadan KM; El-Agnaf M
Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495
[TBL] [Abstract][Full Text] [Related]
18. Anti-RH immunoglobulin therapy for human immunodeficiency virus-related immune thrombocytopenic purpura.
Oksenhendler E; Bierling P; Brossard Y; Schenmetzler C; Girard PM; Seligmann M; Clauvel JP
Blood; 1988 May; 71(5):1499-502. PubMed ID: 2833961
[TBL] [Abstract][Full Text] [Related]
19. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.
Tarantino MD; Young G; Bertolone SJ; Kalinyak KA; Shafer FE; Kulkarni R; Weber LC; Davis ML; Lynn H; Nugent DJ;
J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411
[TBL] [Abstract][Full Text] [Related]
20. [Experiences with anti-Rhesus-D therapy in pretreated patients with idiopathic thrombocytopenia].
Pfeilstöcker M; Waldner R; Reisner R; Heinz R; Pittermann E
Infusionsther Transfusionsmed; 1995 Aug; 22(4):220-4. PubMed ID: 7496120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]